CaringKind, New York’s leading organization in caring for Alzheimer’s disease and dementia patients for the past 30 years, has established an alliance with Cure Alzheimer’s Fund, a not-for-profit organization funding research to prevent, stop, or reverse the neurodegenerative disease.
With the new alliance, people who contact CaringKind to find out more about Alzheimer’s research will have full access to the latest information and resources from Cure Alzheimer’s. On the other hand, Cure Alzheimer’s Fund will ensure that supporters have access to everything they want to know about CaringKind’s state-of-the-art care services and programs.
Cure Alzheimer’s Fund, established in 2004, works tirelessly to financially support the most promising research for Alzheimer’s treatment or to find a cure — 100% of more than $40 million has so far gone to research and initiatives behind some of the most significant breakthroughs in the field, including the famous ‘Alzheimer’s in a Dish’ study.
“Cure Alzheimer’s Fund is honored to have been selected by CaringKind for this important relationship,” said Tim Armour, the organization’s president and chief executive officer, in a news release. “We have learned that many people who are affected by Alzheimer’s disease are also looking to learn more about the research that will lead to a cure, and we are grateful that CaringKind has selected us to help them with that part of their journey.”
CaringKind (formerly the Alzheimer’s Association, New York City Chapter) works directly with the community to advance information, tools and training necessary to provide support to patients and families affected by Alzheimer’s and dementia. The organization offers a professional 24-hour Helpline; personal and family counseling sessions with licensed social workers; a support group network; seminars and training; early stage services; and a wanderer’s safety program that helps protect the safety and wellbeing of patients with severe dementia who may become lost and disoriented.
“As we move ahead, creating and delivering state-of-the-art caregiving programs and services for the Alzheimer’s community, we also know that finding effective therapies for this disease is absolutely critical,” Lou-Ellen Barkan, CaringKind’s president and chief executive officer, said in a press release statement. “We believe that Cure Alzheimer’s Fund is a natural partner for us. Its focus on funding world-class, ground-breaking research will lead to solutions for those struggling with this disease.”